Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure

Sarin, 2009, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL), Hepatol Int, 3, 269, 10.1007/s12072-008-9106-x Sun, 2010, Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure, J Gastroenterol Hepatol, 25, 583, 10.1111/j.1440-1746.2009.06089.x Shu, 2008, The clinic features and the short-term efficacy of entecavir treatment of the HBeAG negative acute-on-chronic hepatitis B liver failure, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 22, 481 Tsai, 2008, Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation, Scand J Gastroenterol, 43, 196, 10.1080/00365520701745693 Ren, 2010, Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis, J Viral Hepat, 17, 887, 10.1111/j.1365-2893.2009.01254.x Hoofnagle, 2007, Management of hepatitis B: summary of a clinical research workshop, Hepatology, 45, 1056, 10.1002/hep.21627 Kamath, 2001, A model to predict survival in patients with end-stage liver disease, Hepatology, 33, 464, 10.1053/jhep.2001.22172 Botta, 2003, MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study, Gut, 52, 134, 10.1136/gut.52.1.134 Malinchoc, 2000, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts, Hepatology, 31, 864, 10.1053/he.2000.5852 Liaw, 2006, Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy, Antivir Ther, 11, 669, 10.1177/135965350601100614 Fattovich, 2003, Natural history of hepatitis B, J Hepatol, 39, S50, 10.1016/S0168-8278(03)00139-9 Papatheodoridis, 2004, Review article: current management of chronic hepatitis B, Aliment Pharmacol Ther, 19, 25, 10.1046/j.1365-2036.2003.01810.x Brunetto, 2002, Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study, J Hepatol, 36, 263, 10.1016/S0168-8278(01)00266-5 Lai, 2006, Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B, N Engl J Med, 354, 1011, 10.1056/NEJMoa051287 Chen, 2009, Short-term entecavir therapy of chronic severe hepatitis B, Hepatobiliary Pancreat Dis Int, 8, 261 Shu, 2009, The efficacy of entecavir treatment on acute-on-chronic liver failure in patients with hepatitis, Zhonghua Chuan Ran Bing Za Zhi, 27, 281 Yu, 2006, Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system, J Gastroenterol Hepatol, 21, 1519, 10.1111/j.1440-1746.2006.04510.x Yu, 2007, The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment, Hepatobiliary Pancreat Dis Int, 6, 492 Wasmuth, 2005, Patients with acute on chronic liver failure display “sepsis-like” immune paralysis, J Hepatol, 42, 195, 10.1016/j.jhep.2004.10.019 Ambrosino, 2003, Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS), Acta Biomed, 74, 7 Zhu, 2005, Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B, World J Gastroenterol, 11, 6936, 10.3748/wjg.v11.i44.6936